NASDAQ:QDEL - Quidel Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$59.48 -0.36 (-0.60 %)
(As of 04/19/2019 08:44 AM ET)
Previous Close$59.84
Today's Range$58.23 - $60.40
52-Week Range$44.27 - $77.63
Volume193,774 shs
Average Volume230,604 shs
Market Capitalization$2.37 billion
P/E Ratio21.09
Dividend YieldN/A
Beta1.37
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology. The company offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye. It also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, the company offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, it provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, the company offers AmpliVue hand-held molecular diagnostic assay platform for the detection of the pathogen; Solana, an amplification and detection system; and Lyra molecular real-time polymerase chain reaction assays. The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail clinics, pharmacies, and wellness screening centers. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.

Receive QDEL News and Ratings via Email

Sign-up to receive the latest news and ratings for QDEL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:QDEL
CUSIP74838J10
Phone858-552-1100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$522.28 million
Cash Flow$4.2335 per share
Book Value$10.82 per share

Profitability

Net Income$74.18 million

Miscellaneous

Employees1,224
Market Cap$2.37 billion
Next Earnings Date5/14/2019 (Estimated)
OptionableOptionable

Quidel (NASDAQ:QDEL) Frequently Asked Questions

What is Quidel's stock symbol?

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

How were Quidel's earnings last quarter?

Quidel Co. (NASDAQ:QDEL) released its earnings results on Wednesday, February, 13th. The company reported $0.75 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.54 by $0.21. The firm had revenue of $132.59 million for the quarter, compared to analysts' expectations of $132.26 million. Quidel had a net margin of 14.20% and a return on equity of 31.73%. The company's quarterly revenue was up 15.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.56 earnings per share. View Quidel's Earnings History.

When is Quidel's next earnings date?

Quidel is scheduled to release their next quarterly earnings announcement on Tuesday, May 14th 2019. View Earnings Estimates for Quidel.

What price target have analysts set for QDEL?

5 equities research analysts have issued 1 year target prices for Quidel's stock. Their forecasts range from $63.00 to $80.00. On average, they anticipate Quidel's share price to reach $73.60 in the next year. This suggests a possible upside of 23.7% from the stock's current price. View Analyst Price Targets for Quidel.

What is the consensus analysts' recommendation for Quidel?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quidel in the last year. There are currently 1 hold rating, 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Quidel.

Has Quidel been receiving favorable news coverage?

News coverage about QDEL stock has trended positive recently, InfoTrie reports. The research group scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Quidel earned a daily sentiment score of 2.7 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the stock's share price in the near term.

Who are some of Quidel's key competitors?

What other stocks do shareholders of Quidel own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Quidel investors own include Netflix (NFLX), Alibaba Group (BABA), NVIDIA (NVDA), Adobe (ADBE), Intel (INTC), Micron Technology (MU), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Energy Transfer LP Unit (ET) and Mastercard (MA).

Who are Quidel's key executives?

Quidel's management team includes the folowing people:
  • Mr. Douglas C. Bryant, Pres, CEO & Director (Age 61)
  • Mr. Randall J. Steward, Chief Financial Officer (Age 65)
  • Mr. Robert J. Bujarski, Sr. VP of Bus. Devel. & Gen. Counsel (Age 51)
  • Dr. Werner Kroll, Sr. VP of R&D (Age 62)
  • Mr. Edward Keith Russell, Sr. VP of Global Commercial Operations (Age 51)

Who are Quidel's major shareholders?

Quidel's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Chartwell Investment Partners LLC (0.12%), Tandem Investment Advisors Inc. (0.03%) and Huntington National Bank (0.00%). Company insiders that own Quidel stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Jack W Schuler, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Thomas D Brown and Werner Kroll. View Institutional Ownership Trends for Quidel.

Which institutional investors are selling Quidel stock?

QDEL stock was sold by a variety of institutional investors in the last quarter, including Chartwell Investment Partners LLC and Tandem Investment Advisors Inc.. Company insiders that have sold Quidel company stock in the last year include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski and Thomas D Brown. View Insider Buying and Selling for Quidel.

Which institutional investors are buying Quidel stock?

QDEL stock was purchased by a variety of institutional investors in the last quarter, including Huntington National Bank. View Insider Buying and Selling for Quidel.

How do I buy shares of Quidel?

Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Quidel's stock price today?

One share of QDEL stock can currently be purchased for approximately $59.48.

How big of a company is Quidel?

Quidel has a market capitalization of $2.37 billion and generates $522.28 million in revenue each year. The company earns $74.18 million in net income (profit) each year or $2.82 on an earnings per share basis. Quidel employs 1,224 workers across the globe.

What is Quidel's official website?

The official website for Quidel is http://www.quidel.com.

How can I contact Quidel?

Quidel's mailing address is 12544 HIGH BLUFF DRIVE SUITE 200, SAN DIEGO CA, 92130. The company can be reached via phone at 858-552-1100 or via email at [email protected]


MarketBeat Community Rating for Quidel (NASDAQ QDEL)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  326 (Vote Outperform)
Underperform Votes:  277 (Vote Underperform)
Total Votes:  603
MarketBeat's community ratings are surveys of what our community members think about Quidel and other stocks. Vote "Outperform" if you believe QDEL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QDEL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/19/2019 by MarketBeat.com Staff

Featured Article: Balance Sheet

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel